An oncolytic virus-delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment.
DePeaux K, Rivadeneira DB, Lontos K, Dean VG, Gunn WG, Watson MJ, Yao T, Wilfahrt D, Hinck C, Wieteska L, Thorne SH, Hinck AP, Delgoffe GM.
DePeaux K, et al. Among authors: gunn wg.
J Exp Med. 2023 Oct 2;220(10):e20230053. doi: 10.1084/jem.20230053. Epub 2023 Aug 8.
J Exp Med. 2023.
PMID: 37552475
Free PMC article.